Trials / Completed
CompletedNCT00535938
MDs on Botox Utility (MOBILITY)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,372 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 14 Years
- Healthy volunteers
- Not accepted
Summary
The MOBILITY Project is a prospective, non-randomized, observational, multi-centre evaluation of Health Utility via the SF-12® Health Survey Scores and the SF-6D in patients receiving BOTOX® for therapeutic use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | botulinum toxin type A | There will be no protocol-mandated intervention with regard to physician treatment choice or management of patient condition once the patient is enrolled in the project. |
Timeline
- Start date
- 2007-09-01
- Primary completion
- 2013-09-01
- Completion
- 2013-09-01
- First posted
- 2007-09-27
- Last updated
- 2014-09-10
- Results posted
- 2014-09-10
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00535938. Inclusion in this directory is not an endorsement.